z-logo
open-access-imgOpen Access
Chymase inhibitor TY-51469 in therapy of inflammatory bowel disease
Author(s) -
Weixin Liu,
Ying Wang,
Li-Xuan Sang,
Shen Zhang,
Ting Wang,
Feng Zhou,
Shouzhi Gu
Publication year - 2016
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v22.i5.1826
Subject(s) - intraperitoneal injection , gastroenterology , medicine , inflammatory bowel disease , colitis , saline , chymase , immunohistochemistry , immunology , ulinastatin , group a , inflammation , pathology , endocrinology , mast cell , disease
To investigate the effect of chymase inhibitor TY-51469 in the therapy of inflammatory bowel disease and the underlying mechanism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here